RT Journal Article
SR Electronic
T1 Genome-wide association analysis reveals insights into the molecular etiology underlying dilated cardiomyopathy
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.09.28.23295408
DO 10.1101/2023.09.28.23295408
A1 Zheng, Sean L
A1 Henry, Albert
A1 Cannie, Douglas
A1 Lee, Michael
A1 Miller, David
A1 McGurk, Kathryn A
A1 Bond, Isabelle
A1 Xu, Xiao
A1 Issa, Hanane
A1 Francis, Catherine
A1 De Marvao, Antonio
A1 Theotokis, Pantazis I
A1 Buchan, Rachel J
A1 Speed, Doug
A1 Abner, Erik
A1 Adams, Lance
A1 Aragam, Krishna G
A1 Ärnlöv, Johan
A1 Axelsson Raja, Anna
A1 Backman, Joshua D
A1 Baksi, John
A1 Barton, Paul JR
A1 Biddinger, Kiran J
A1 Boersma, Eric
A1 Brandimarto, Jeffrey
A1 Brunak, Søren
A1 Brundgaard, Henning
A1 Carey, David J
A1 Charron, Philippe
A1 Cook, James P
A1 Cook, Stuart A
A1 Denaxas, Spiros
A1 Deleuze, Jean-François
A1 Doney, Alexander S
A1 Elliott, Perry
A1 Erikstrup, Christian
A1 Esko, Tõnu
A1 Farber-Eger, Eric H
A1 Finan, Chris
A1 Garnier, Sophie
A1 Ghouse, Jonas
A1 Giedraitis, Vilmantas
A1 Guðbjartsson, Daniel F
A1 Haggerty, Christopher M
A1 Halliday, Brian P
A1 Helgadottir, Anna
A1 Hemingway, Harry
A1 Hillege, Hans
A1 Kardys, Isabella
A1 Lind, Lars
A1 Lindgren, Cecilia M
A1 Lowery, Brandon D
A1 Manisty, Charlotte
A1 Margulies, Kenneth B
A1 Moon, James C
A1 Mordi, Ify R
A1 Morley, Michael P
A1 Morris, Andrew D
A1 Morris, Andrew P
A1 Morton, Lori
A1 Noursadeghi, Mahdad
A1 Ostrowski, Sisse R
A1 Owens, Anjali T
A1 Palmer, Colin NA
A1 Pantazis, Antonis
A1 Pedersen, Ole BV
A1 Prasad, Sanjay K
A1 Shekhar, Akshay
A1 Smelser, Diane T
A1 Srinivasan, Sundarajan
A1 Stefansson, Kari
A1 Sveinbjörnsson, Garðar
A1 Syrris, Petros
A1 Tammesoo, Mari-Liis
A1 Tayal, Upasana
A1 Teder-Laving, Maris
A1 Thorgeirsson, Guðmundur
A1 Thorsteinsdottir, Unnur
A1 Tragante, Vinicius
A1 Trégouët, David-Alexandre
A1 Treibel, Thomas A
A1 Ullum, Henrik
A1 Valdes, Ana M
A1 van Setten, Jessica
A1 van Vugt, Marion
A1 Veluchamy, Abirami
A1 Verschuuren, W.M.Monique
A1 Villard, Eric
A1 Yang, Yifan
A1 ,
A1 ,
A1 ,
A1 ,
A1 Asselbergs, Folkert W
A1 Cappola, Thomas P
A1 Dube, Marie-Pierre
A1 Dunn, Michael E
A1 Ellinor, Patrick T
A1 Hingorani, Aroon D
A1 Lang, Chim C
A1 Samani, Nilesh J
A1 Shah, Svati H
A1 Smith, J Gustav
A1 Vasan, Ramachandran S
A1 O’Regan, Declan P
A1 Holm, Hilma
A1 Noseda, Michela
A1 Wells, Quinn
A1 Ware, James S
A1 Lumbers, R Thomas
YR 2023
UL http://medrxiv.org/content/early/2023/09/29/2023.09.28.23295408.abstract
AB Dilated cardiomyopathy (DCM) is a clinical disorder characterised by reduced contractility of the heart muscle that is not explained by coronary artery disease or abnormal haemodynamic loading. Although Mendelian disease is well described, clinical testing yields a genetic cause in a minority of patients. The role of complex inheritance is emerging, however the common genetic architecture is relatively unexplored. To improve our understanding of the genetic basis of DCM, we perform a genome-wide association study (GWAS) meta-analysis comprising 14,255 DCM cases and 1,199,156 controls, and a multi-trait GWAS incorporating correlated cardiac magnetic resonance imaging traits of 36,203 participants. We identify 80 genetic susceptibility loci and prioritize 61 putative effector genes for DCM by synthesizing evidence from 8 gene prioritization strategies. Rare variant association testing identifies genes associated with DCM, including MAP3K7, NEDD4L, and SSPN. Through integration with single-nuclei transcriptomics from 52 end-stage DCM patients and 18 controls, we identify cellular states, biological pathways, and intercellular communications driving DCM pathogenesis. Finally, we demonstrate that a polygenic score predicts DCM in the general population and modulates the penetrance of rare pathogenic and likely pathogenic variants in DCM-causing genes. Our findings may inform the design of novel clinical genetic testing strategies incorporating polygenic background and the genes and pathways identified may inform the development of targeted therapeutics.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by funding from the British Heart Foundation [RE/18/4/34215, FS/IPBSRF/22/27059, FS/15/81/31817, FS/ICRF/21/26019, RG/19/6/34387, BC/F/21/220106, FS/18/65/34186]; the Medical Research Council [MC_UP_1605/13]; Wellcome Trust [107469/Z/15/Z]; the National Institute for Health Research (NIHR) Imperial College Biomedical Research Centre; NIHR Royal Brompton Cardiovascular Biomedical Research Unit; Sir Jules Thorn Charitable Trust [21JTA]; National Heart Lung Institute Foundation; Royston Centre for Cardiomyopathy Research; Rosetrees Trust. This research has been conducted in part using the UK Biobank Resource under Application Numbers 9922, 15422, 18545, 40616 and 47602. Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesData from UK Biobank can be requested from the UK Biobank Access Management System. Data from 100,000 Genomes Project can be accessed following application to join the Genomics England Clinical Interpretation Partnership. GWAS summary statistics will be made available on the Cardiovascular Disease Knowledge Portal (https://cvd.hugeamp.org/) upon publication following peer-review. The PGS will be made available on the Polygenic Score Catalog (www.pgscatalog.org) following peer-review. The raw single nuclei gene expression dataset is available from CZI CELLxGENE (cellxgene.cziscience.com). The analyses reported in this article rely on previously published software, as detailed in the Methods.